Table 2.
Results of fluorescence in situ hybridization analysis
| No. of Patients (%) (n = 34) | |
| t(11;18)(q21;q21) | 0 (0%) |
| t(14;18)(q32;q21) | 1(3%) |
| trisomy 18* | 16 (47%) |
| trisomy 3** | 21 (62%) |
| trisomy 7 | 2 (6%) |
| trisomy 12 | 0 (0%) |
| MALT 1 gene amplification | 1 (3%) |
| Normal | 3 (9%) |
* There were eight cases with trisomy 18 alone and eight cases with trisomy 18 and trisomy 3.
** There were eleven cases with trisomy 3 alone, eight with trisomy 3 and trisomy 18, one with t(14;18)(q32;q21), and one with MALT1 gene amplification.